G

Gemphire Therapeutics

2 employees

Gemphire Therapeutics manufactures and markets Gemcabene, an LDL cholesterol-lowering medication.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Therapeutics
Cardiovascular and NASH
Manufacturing

Date founded

2011

Funding rounds raised

Total raised

$11M

from 2 investors over 2 rounds

G

Gemphire Therapeutics raised undisclosed on January 1, 2020

Investors: Excel Venture Management, LLC

G

Gemphire Therapeutics raised $11M on April 27, 2016

Investors: Grand Angels

FAQ